The European nanomedicines market is projected to grow at a modest CAGR of 10.9% during the forecast period (2021-2027). The major aspect that drives the growth of the market includes the rising burden of various diseases in the region. Owing to this, there has been an increased focus of the government along with other organizations regarding the development of novel treatment technologies including nanomedicines. For instance, organizations such as the European Society for Nanomedicine (ESNAM) and the European Technology Platform on Nanomedicine (ETPN) focus on promoting the research and clinical applications of nanomedicine for the betterment of humanity and the environment. Hence, the aforementioned factors are likely to drive the growth of the market in the region over the forecast period.
To Request a Sample of our Report on European Nanomedicines Market: https://www.omrglobal.com/request-sample/europe-nanomedicines-market
The European nanomedicines market is segmented on the basis of indication type and application. Based on the indication type, the market is segmented as cardiovascular diseases, neurological diseases, infectious diseases, oncological diseases, orthopedic diseases, and others. The other segment includes urological disease and ophthalmic diseases. The cardiovascular diseases segment is likely to hold a substantial share in the market over the forecast period. Based on the applications, the market is segmented as drug delivery, active implants, vaccines, diagnostic imaging, biomaterials, regenerative medicines, and other applications. The other segment includes tissue regeneration. The drug delivery segment is likely to hold a substantial share in the market over the forecast period.
(Get 15% Discount on Buying this Report)
A full Report of European Nanomedicines Market is Available at: https://www.omrglobal.com/industry-reports/europe-nanomedicines-market
European Nanomedicines Market Segmentation
By Indication Type
- Cardiovascular Diseases
- Neurological Diseases
- Infectious Diseases
- Oncological Diseases
- Orthopedic Diseases
- Other Diseases (Urological Disease, Ophthalmic Diseases)
By Application
- Drug Delivery
- Active Implants
- Vaccines
- Diagnostic Imaging
- Biomaterials
- Regenerative Medicines
- Other Applications (Tissue Regeneration)
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
